Filing Details

Accession Number:
0000950142-15-002472
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-20 16:30:54
Reporting Period:
2015-11-18
Filing Date:
2015-11-20
Accepted Time:
2015-11-20 16:30:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1415336 Zeltiq Aesthetics Inc ZLTQ Electromedical & Electrotherapeutic Apparatus (3845) 270119051
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1172252 N Andrew Schiff 888 Seventh Avenue
12Th Floor
New York NY 10106
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-11-18 41,181 $30.78 2,556,561 No 4 S Indirect By Aisling Capital III, LP
Common Stock Disposition 2015-11-18 152,827 $31.10 2,403,734 No 4 S Indirect By Aisling Capital III, LP
Common Stock Disposition 2015-11-19 45,281 $29.59 2,358,453 No 4 S Indirect By Aisling Capital III, LP
Common Stock Disposition 2015-11-19 4,719 $31.39 2,353,734 No 4 S Indirect By Aisling Capital III, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Aisling Capital III, LP
No 4 S Indirect By Aisling Capital III, LP
No 4 S Indirect By Aisling Capital III, LP
No 4 S Indirect By Aisling Capital III, LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,938 Direct
Footnotes
  1. Consists of 1,152 shares of common stock, par value $0.001 per share ("Common Stock") and 5,786 restricted stock units, issued pursuant to the 2011 Equity Incentive Plan of the Issuer. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units vest in 12 ratable monthly installments from the date of grant, subject to Mr. Schiff's continued service with the Issuer. As previously reported, on June 17, 2015, Mr. Schiff was granted 4,996 such restricted stock units, of which 2,081 have vested to date. Also as previously reported, on July 22, 2015, Mr. Schiff was granted an additional 790 such restricted stock units, of which 197 have vested to date.
  2. Includes 87 shares of Common Stock held by a trust for the benefit of Mr. Schiff's children.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.56 to $30.99, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.77, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.46 to $29.80, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.50, inclusive.
  7. The shares are directly held by Aisling Capital III, LP ("Aisling") and are indirectly held by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III, LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling. Dr. Andrew Schiff is a member of the Board of Directors of Zeltiq Aesthetics, Inc.
  8. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6) to this Form 4.